Tag: COVID-19

Survey: Two in five Americans likely to attend large holiday gatherings despite COVID-19

Editor's Note A new national survey released November 12 by researchers at The Ohio State University Wexner Medical Center, Columbus, finds that a majority of Americans plan to take precautions at holiday gatherings, but many also will put themselves at risk. Nearly two in five surveyed say they will likely…

Read More

By: Judy Mathias
November 12, 2020
Share

Job insecurity linked to anxiety, depression in young adults during COVID-19

Editor's Note New research from the University of Toronto, Ontario, Canada; Massachusetts General Hospital, Boston; and University of California, San Francisco; finds that young adults in the US are experiencing a significant mental health burden as a result of job insecurity during the COVID-19 pandemic. The analysis shows that since…

Read More

By: Judy Mathias
November 12, 2020
Share

Medicare to cover monoclonal antibody COVID-19 treatments

Editor's Note The Centers for Medicare and Medicaid Services (CMS) on November 10 announced that Medicare will cover out-of-pocket costs for monoclonal antibody drugs for COVID-19 during the public health emergency. The agency’s coverage includes Eli Lilly’s bamlanivimab, which recently received an emergency use authorization from the Food and Drug…

Read More

By: Judy Mathias
November 12, 2020
Share

Increase in firearm injuries after COVID-19 stay-at-home orders

Editor's Note This study from the University of Pennsylvania, Philadelphia, finds that the social isolation brought on by stay-at-home orders (SAHO) issued during the COVID-19 pandemic resulted in an increase in intentional penetrating injuries, especially from firearms, and the injuries remain at high levels today. As of October 19, Philadelphia…

Read More

By: Judy Mathias
November 10, 2020
Share

ECRI: More than half of disposable gowns tested don’t meet protection standards

Editor's Note A new analysis by ECRI shows that 52% of the disposable isolation gowns it tested failed to meet standard levels of protection, putting healthcare workers at risk of exposure to bloodborne or other pathogens as well as COVID-19. ECRI announced November 10 that it has issued a high-priority…

Read More

By: Judy Mathias
November 10, 2020
Share

AI tool detects COVID-19 by listening to patients’ coughs

Editor's Note Researchers from the Massachusetts Institute of Technology, Cambridge, have developed an artificial intelligence (AI) tool that can detect COVID-19 by listening to patients’ coughs, regardless if they are symptomatic or not. To build the tool, the researchers solicited audio recordings of patients coughing and accompanying information about their…

Read More

By: Judy Mathias
November 10, 2020
Share

FDA issues EUA for first test to detect neutralizing antibodies after COVID-19

Editor's Note The Food and Drug Administration (FDA) on November 6 issued an emergency use authorization (EUA) for the first serology test (GenScript USA Inc) to identify patients with neutralizing antibodies after a COVID-19 infection. Neutralizing antibodies have reduced the infection of cells in the laboratory, but their effects in…

Read More

By: Judy Mathias
November 10, 2020
Share

Perioperative Nurse Week is November 8 to 14

Editor's Note Every year, AORN chooses a week to focus attention on the work of more than 160,000 nurses who advocate for surgical patients. This year the week is celebrated November 8 to 14. During the week, perioperative nurses are honored by colleagues and communities to highlight the ways nurses…

Read More

By: Judy Mathias
November 9, 2020
Share

Pfizer, BioNTech COVID-19 vaccine more than 90% effective, EUA application could come next week

Editor's Note Pfizer and BioNTech announced November 9 that their COVID-19 vaccine is more than 90% effective 7 days after the second dose in preventing COVID-19 infection in participants without evidence of prior infection. This means that protection is achieved 28 days after initiation of the vaccination, which consists of…

Read More

By: Judy Mathias
November 9, 2020
Share

Final report on Remdesivir study for treatment of COVID-19

Editor's Note The November 5 final report on data from this double-blind, randomized, placebo-controlled study of intravenous remdesivir in adults hospitalized with COVID-19 and lower respiratory tract infection shows that remdesivir was superior to placebo in shortening the time to recovery. A total of 1,062 patients were randomized to remdesivir…

Read More

By: Judy Mathias
November 5, 2020
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat